157 related articles for article (PubMed ID: 8450707)
1. Inhibition of naloxone-precipitated withdrawal jumping by i.c.v. and i.t. administration of saline in morphine-dependent mice.
Miyamoto Y; Takemori AE
Life Sci; 1993; 52(13):1129-34. PubMed ID: 8450707
[TBL] [Abstract][Full Text] [Related]
2. Sites of action of naloxone in precipitating withdrawal jumping in morphine-dependent mice: investigations by the ED50 value and CNS content of naloxone.
Miyamoto Y; Takemori AE
Drug Alcohol Depend; 1993 Apr; 32(2):163-7. PubMed ID: 8389690
[TBL] [Abstract][Full Text] [Related]
3. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
[TBL] [Abstract][Full Text] [Related]
4. Relative involvement of supraspinal and spinal mu opioid receptors in morphine dependence in mice.
Miyamoto Y; Takemori AE
Life Sci; 1993; 52(12):1039-44. PubMed ID: 8383266
[TBL] [Abstract][Full Text] [Related]
5. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
[TBL] [Abstract][Full Text] [Related]
6. Precipitation of spinally mediated withdrawal signs by intrathecal administration of naloxone and the mu-receptor antagonist CTP in morphine-dependent mice.
Shook J; Kazmierski W; Hruby V; Burks T
NIDA Res Monogr; 1988; 81():143-8. PubMed ID: 2900467
[TBL] [Abstract][Full Text] [Related]
7. Role of intracellular calcium on the modulation of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
Ohsawa M; Kamei J
Brain Res; 1999 Jan; 815(2):424-30. PubMed ID: 9878862
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Tan-No K; Sato T; Shimoda M; Nakagawasai O; Niijima F; Kawamura S; Furuta S; Sato T; Satoh S; Silberring J; Terenius L; Tadano T
Neuropeptides; 2010 Jun; 44(3):279-83. PubMed ID: 20189644
[TBL] [Abstract][Full Text] [Related]
9. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Zarrindast MR; Mohajeri S
Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
[TBL] [Abstract][Full Text] [Related]
10. Opiate dependence following acute injections of morphine and naloxone: the assessment of various withdrawal signs.
Ritzmann RF
Pharmacol Biochem Behav; 1981 Apr; 14(4):575-7. PubMed ID: 7195040
[TBL] [Abstract][Full Text] [Related]
11. Acutely administered clozapine does not modify naloxone-induced withdrawal jumping in morphine-dependent mice.
Ballard TM; McAllister KH
Pharmacol Biochem Behav; 1999 Feb; 62(2):285-90. PubMed ID: 9972695
[TBL] [Abstract][Full Text] [Related]
12. Influence of histamine, cimetidine and pyrilamine on naloxone-induced jumping in morphine-dependent mice.
Zarrindast MR; Assadi E; Oryan S; Torkaman-Boutorabi A; Sahebgharani M
Eur J Pharmacol; 2003 Jun; 471(2):105-12. PubMed ID: 12818697
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of morphine withdrawal diarrhea and jumping in mice by the peripherally selective opioid antagonist SR 58002 C.
Bianchetti A; Guidice A; Nava F; Manara L
Life Sci; 1986 Dec; 39(24):2297-303. PubMed ID: 3796195
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of digoxin, ouabain and milrinone on naloxone-precipitated withdrawal syndrome in mice.
Bai YL; Chu QJ; Li J; Chen YY; Li WJ; Zhang Q
Eur J Pharmacol; 2012 Nov; 694(1-3):69-74. PubMed ID: 22960325
[TBL] [Abstract][Full Text] [Related]
15. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
16. Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
Kamei J; Ohsawa M
Life Sci; 1997; 60(15):PL223-8. PubMed ID: 9096248
[TBL] [Abstract][Full Text] [Related]
17. Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.
Yamaguchi T; Hagiwara Y; Tanaka H; Sugiura T; Waku K; Shoyama Y; Watanabe S; Yamamoto T
Brain Res; 2001 Aug; 909(1-2):121-6. PubMed ID: 11478928
[TBL] [Abstract][Full Text] [Related]
18. Assessment of acute and chronic morphine dependence in male and female mice.
Kest B; Palmese CA; Hopkins E; Adler M; Juni A
Pharmacol Biochem Behav; 2001 Sep; 70(1):149-56. PubMed ID: 11566152
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen-rich saline attenuates anxiety-like behaviors in morphine-withdrawn mice.
Wen D; Zhao P; Hui R; Wang J; Shen Q; Gong M; Guo H; Cong B; Ma C
Neuropharmacology; 2017 May; 118():199-208. PubMed ID: 28359771
[TBL] [Abstract][Full Text] [Related]
20. Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
Funada M; Suzuki T; Sugano Y; Tsubai M; Misawa M; Ueda H; Misu Y
Life Sci; 1994; 54(8):PL113-8. PubMed ID: 7509021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
